This announcement contains inside information for the purposes
of the UK Market Abuse Regulation. Upon the publication of this
announcement via a Regulatory Information Service, this inside
information is now considered to be in the public
domain.
18 September 2024
RESULTS FOR THE YEAR ENDED 31
MAY 2024
Progress on strategic
priorities and portfolio transformation
Continued business momentum
despite macro-economic challenges in Nigeria
Jonathan Myers, Chief Executive Officer, said:
"Over the last
twelve months, we have made continued operational progress and
delivered against the strategic priorities set out at the start of
the year, against the backdrop of macro-economic challenges. At the
same time, we have taken the important first steps to transform our
business and maximise shareholder value, by refocusing our
portfolio on where we can be most competitive.
"The period was marked by a 70% devaluation of the Nigerian
Naira, which has had significant implications on our reported
financials. We have worked hard to mitigate the impact of this on
the Group, while continuing to serve Nigerian consumers who are
facing unprecedented inflation and economic difficulties.
Elsewhere, we significantly improved trading in our UK Personal
Care business as we returned Carex to growth, maintained our
momentum in ANZ, delivered a return to volume-led revenue growth in
Indonesia in Q4 and led Childs Farm to a year of profitable,
double-digit revenue growth.
"The favourable trends of the second half of FY24 have
continued into the new financial year. We are progressing with our
plans to sell St. Tropez and have received a number of expressions
of interest for our African business, recognising the potential of
our brands and people, which could lead to a partial or full
sale.
"Against this backdrop, we remain confident in the
long-term potential for PZ Cussons as a business with stronger
brands in a more focused portfolio, delivering sustainable,
profitable growth."
£m
unless otherwise stated
|
Adjusted
|
Statutory
|
2024
|
2023
|
variance
|
2024
|
2023
|
variance
|
Revenue
|
527.9
|
656.3
|
(19.6)%
|
527.9
|
656.3
|
(19.6)%
|
LFL revenue growth
|
4.4%
|
6.1%
|
|
|
Operating profit
|
58.3
|
73.3
|
(20.5)%
|
(83.7)
|
59.7
|
n.m.
|
Operating margin
|
11.0%
|
11.2%
|
(20)bps
|
(15.9)%
|
9.1%
|
n.m.
|
Profit before tax
|
44.7
|
74.1
|
(39.7)%
|
(95.9)
|
61.8
|
n.m.
|
Basic earnings per share
|
8.02p
|
11.23p
|
(28.6)%
|
(13.60)p
|
8.70p
|
n.m.
|
Dividend per share
|
|
3.60p
|
6.40p
|
(43.8)%
|
See page 14 for definitions of key
terms and page 15 for the reconciliation between Alternative
Performance Measures and Statutory results.
'n.m.' represents non-meaningful growth
rates.
With the exception of LFL revenue
growth, % changes are shown at actual FX rates.
Summary
Financial results
· As indicated in previous announcements, the devaluation of the
Nigerian Naira during FY24 has had a significant impact on PZ
Cussons' financial results. The value of the Naira versus Sterling
was, on average, 57% lower during FY24 compared to FY23,
contributing to a year-on-year reduction in revenue, earnings and
cash [1].
·
Like-for-like ('LFL') revenue growth was 4.4%,
driven by price/mix improvements of 6.8% and a 2.4% decline in
volume. This was driven primarily by growth in Nigeria, as we
offset cost inflation with pricing. Excluding Africa, LFL revenue
declined 2.6%. For the Group as a whole,
revenue fell by 19.6% on a reported basis.
·
Revenue trends improved across each region
throughout the year, with growth in both Group revenue and volume
in Q4.
·
Profit before tax declined by 39.7%, reflecting
the reduction in operating profit and increased interest charges.
EPS declined by 28.6% as the decline in PBT was partly offset by a
reduced effective tax rate.
·
Gross debt reduced significantly, from £251
million as at 31 May 2023 to £167 million as at 31 May 2024,
reflecting the repatriation of c.£50 million of cash from Nigeria
and free cash flow generation elsewhere.
[1] The Naira was 70% lower between 31 May 2023 and 31 May 2024
and was 57% lower on average for the financial year as a whole. All
comparisons are made to Sterling unless otherwise
stated.
Delivering against the
strategy
·
Delivery against our four stated FY24 strategic
priorities:
1. Simplifying and strengthening Nigeria:
addressing funding challenges with improved US Dollar sourcing,
enabling cash repatriation and reduced Group gross borrowings, with
revenue growth driven by pricing and continued increases in the
number of customers served directly.
2. UK growth: strong revenue performance
in our largest market with double-digit growth in Original Source,
Imperial Leather and Childs Farm, and a return to growth of Carex
for the full year.
3. Expansion from the core: initial
in-store launch of Childs Farm in the US and continued growth in
Germany, with further expansion in the UK, including the launch in
Marks & Spencer in August 2024.
4. Transforming capabilities:
strengthened organisation with a simplified UK structure and
improved Group-wide brand-building and digital
capabilities.
Portfolio transformation
Following our announcement in April
2024, we are on track with our plans to maximise shareholder value
following a strategic review of brands and geographies:
·
St.
Tropez: Plans to dispose of the St.
Tropez business are progressing.
·
Africa: The Board has received a number of expressions of interest in
the Africa business and it is possible that this could lead to a
partial or full sale.
The intent of these actions is to
refocus on where the business can be most competitive. Further
updates will be provided as appropriate.
Dividend
The Board announces its intention to
declare an interim dividend of 2.10p per share, down 44% compared
to last year's final dividend of 3.73p. This represents a full year
dividend of 3.60p which is also down 44%, reflecting the impact of
the Naira devaluation on earnings per share while maintaining an
earnings cover of approximately two times
[2].
The dividend will be paid on 4
December 2024 to shareholders on the register at the close of
business on 1 November 2024.
[2] Reference is made to an Interim, rather than Final, dividend
due to the Distributable Reserves in the relevant Company being
negative as at 31 May 2024. The Group has subsequently reversed
this position and future dividend payments will not be
affected.
FY25 outlook
Current trading
​
The FY25 financial year has started
positively, with Group LFL revenue growth of 4.7% driven by strong
growth in both our Africa and Europe and Americas regions, partly
offset by adverse phasing of shipping in Asia.
Operating profit guidance
Guidance has been provided to
separate the impact of the Naira uncertainty on the Group's
results. Assuming that the average FX rates in Q1 FY25 prevail for
the balance of the year, the Group expects to deliver operating
profit in the range of £47-53 million [3]. Based on
these exchange rates, FY24 operating profit would have been
approximately £40 million.
Movements in the Naira are expected
to be a key determinant of the Group's reported FY25 result. Such
movements impact the translation of local currency earnings when
reported in Sterling, as well as the foreign exchange re-valuation
of intra-group liabilities. The operating profit sensitivity
related to the latter has increased in FY25 due to necessary
accounting changes brought about by the increased likelihood of the
repayment of inter-company loans following the receipt of
expressions of interest relating to our African business. We will
provide an analysis of the impact of the revaluation of these
liabilities on our earnings in future financial results.
[3] Historic and current FX rates are provided on page
13.
For further information
please contact:
Investors
Simon Whittington - IR and Corporate
Development Director +44 (0) 77 1137
2928
Media
Headland PZCussons@headlandconsultancy.com
+44 (0) 20 3805 4822
Susanna Voyle, Stephen Malthouse and
Charlie Twigg
Investor and Analyst
conference call
PZ Cussons' management will host a
presentation for analysts and institutional investors at 9.00 am UK
time to present the results and provide the opportunity for
Q&A. The event will be held at:
Deutsche Numis UK
45 Gresham Street
London
EC2V 7BF
A webcast of the presentation is
available at the link below and will also be available via our
corporate website: www.pzcussons.com.
Audience Webcast link:
https://www.investis-live.com/pzcussons/66cf23de58fb260c0062b9cb/fesx
Dial in: +44
20 3936 2999 / +44 800 358 1035
Access code: 265662
Notes to
Editors
About PZ Cussons
PZ Cussons is a FTSE 250 listed
consumer goods business headquartered in Manchester, UK. We employ
over 2,600 people across our operations in Europe, North America,
Asia-Pacific and Africa. Since our founding in 1884, we have been
creating products to delight, care for and nourish consumers.
Across our core categories of Hygiene, Baby and Beauty, our trusted
and well-loved brands include Carex, Childs Farm, Cussons Baby,
Imperial Leather, Morning Fresh, Original Source, Premier,
Sanctuary Spa and St. Tropez. Sustainability and the wellbeing of
our employees and communities everywhere are at the heart of our
business model and strategy, and captured by our purpose: For
everyone, for life, for good.
Cautionary note regarding forward-looking
statements
This announcement contains certain
forward-looking statements relating to expected or anticipated
results, performance or events. Such statements are subject to
normal risks associated with the uncertainties in our business,
supply chain and consumer demand, along with risks associated with
macroeconomic, political and social factors in the markets in which
we operate. Whilst we believe that the expectations reflected
herein are reasonable based on the information we have as of the
date of this announcement, actual outcomes may vary significantly
owing to factors outside the control of the PZ Cussons Group, such
as cost of materials or demand for our products, or within our
control such as our investment decisions, allocation of resources
or changes to our plans or strategy. The PZ Cussons Group expressly
disclaims any obligation to revise forward-looking statements made
in this or other announcements to reflect changes in our
expectations or circumstances. No reliance may be placed on the
forward-looking statements contained within this
announcement.
Introduction from our Chief Executive
Officer
Four years ago, we embarked upon a
multi-year journey to transform PZ Cussons - a company with
inherently strong brands, excellent people and attractive
underlying markets and categories. We defined our strategy by
focusing on the core categories of Hygiene, Baby and Beauty in our
four priority markets: the UK, ANZ, Indonesia, and Nigeria. We have
been prioritising spending on those brands where we see the
greatest opportunity for return on investment: our Must Win
Brands. Underpinning this strategy, our growth is
enabled by strengthening our capabilities, talent, leadership,
culture, and our approach to sustainability. Running through
everything we do is a drive to reduce complexity across our
business. As such, we have summarised our strategy around five choices: Build Brands,
Serve Consumers, Reduce Complexity, Develop People and Grow
Sustainably.
Over this time, we have come a long
way. We have strengthened our brands, re-energised and
professionalised the organisation, and raised the bar on
performance. Nevertheless, our FY24 reported results fell short of
our initial expectations, primarily due to the macroeconomic
developments in Nigeria which, as we indicated last year, would
significantly affect our results. The 70% currency
devaluation [4] over the course of the financial year has, therefore, caused a
significant impact not only on our local business but also on the
profitability and financial position of the Group.
Against this backdrop, our efforts
have been focused on our strategic priorities for FY24, which are
detailed below. We have, therefore, sought to address our
challenges and opportunities head-on. In particular, we have made
good progress in strengthening and simplifying our
operations in Nigeria to the point where the business no longer
relies on lending from the Group to provide it with US Dollars.
There is now minimal surplus cash in Nigeria following the
repatriation of cash to the UK.
As we announced in April 2024, there
is much more to do to deliver a transformation of PZ Cussons and
unlock the full potential of the business. Despite the progress
already made in reducing complexity - both in terms of our
portfolio footprint and operations - the Group remains too complex
for its size. Resource is spread too thinly to generate
consistently high returns and we cannot always fully benefit from
competitive advantages where we have them. There is a significant
opportunity for the Group to out-compete both larger multinational
players and smaller local players by concentrating on a strong
portfolio of locally-loved brands with operations focused in
markets where we can leverage our existing infrastructure, such as
manufacturing or commercial capabilities. However, there is only so
much that can be achieved within the framework of our existing
portfolio, which spans multiple markets and categories. To this
end, the disposal of St. Tropez is progressing and we are now
considering a partial or full sale of our African business, having
received expressions of interest from a number of
parties.
We remain confident in the long-term
potential for PZ Cussons as a business with stronger brands in a
more focused portfolio, delivering sustainable, profitable
growth.
On behalf of the Board, I would like
to thank the PZ Cussons teams for their continued energy and
tenacity amidst challenging conditions and our suppliers and
customers for their valued partnership.
[4] Reference to devaluation is based upon May 31 2023 to May 31
2024.
Delivering against FY24 strategic priorities
Throughout the year, we made good
progress across the year's strategic priorities:
#1: Further simplifying and strengthening
Nigeria
A major focus for the Group
throughout the year has been foreign exchange and cash management
activity in Nigeria. We have reduced our requirements for foreign
currency whilst expanding and diversifying our access to US Dollars
so we can repatriate cash from Nigeria and repay UK borrowings. In
doing so, we have been able to reduce gross borrowings and limit
the impact of further currency devaluation. Specifically, we have
repatriated approximately £50 million over the course of the year,
resulting in minimal surplus cash in Nigeria as at the end of the
year. Critically, the business will effectively be self-funding
going forward, with little reliance on Group lending.
We have been focused on
strengthening the operations of the Nigerian business, and given
the number of competitors exiting the market, there have been
opportunities for market share gains.
In addition, during the year, we
identified more non-trading assets in Nigeria to be divested. We
expect these assets to be sold during the course of FY25 and
proceeds will be repatriated to the UK and used to reduce gross
debt further.
Our plans to de-list and buy out
minority shareholders of our Nigerian-listed entity were paused
during the year, in part as a result of the Group's broader
portfolio transformation plans, announced in April 2024.
#2: Returning the UK to sustainable, profitable
growth
Our UK Personal Care business has
performed very strongly in FY24 with double-digit revenue growth
and a significant margin improvement. This performance is the
result of a strengthened leadership team and a more determined
focus on building back core executional capabilities. We are more
disciplined now in focusing on the right brands, in the right
sizes, in the right channels at the right prices. We have seen
particular success with Original Source - growing revenue by over
20% and reaching its highest-ever levels of household penetration.
There has been successful Revenue Growth Management ('RGM')
activity across the portfolio, and continued success with the
re-staging of Imperial Leather and the launch of Cussons Creations.
Carex also returned to growth for the year as a whole, supported by
its successful collaboration with the Gruffalo and the launch of
the one-litre refill packs.
Looking ahead, there remains further
opportunity to regain previous profitability levels in our UK
Personal Care business and we are working to improve the
performance of our other UK brands, such as Sanctuary Spa, Charles
Worthington, and Fudge, which have previously been managed as part
of our Beauty business unit.
#3: Driving further expansion from the core
We have had continued success with
Childs Farm during the year, which reported its second year of
double-digit revenue growth. In addition, we have seen further
growth in distribution, with successful international launches in
the year. In the US, we continued to build our position with
Amazon, and in August 2024, we launched the brand in Wegmans, a
premium grocery chain, through its online and in-store offerings.
In Germany, the brand was launched via dm - a major retailer - and
our Sleep Mist product became the number one online SKU within the
category in dm.
Original Source in Spain continues
to develop, and during the year we extended our distribution in one
of the largest hypermarkets in Spain, Carrefour.
#4: Continuing to transform capabilities
We continue to strengthen
the business's capabilities to support our growth plans.
During the year, we made a significant change to simplify our
organisational structure, allowing us to strengthen our UK
businesses while improving brand-building capabilities and
strengthening growth plans across the Group.
Firstly, having previously operated
as two separate business units, with two leadership, two commercial
and two support teams, we have made good progress in combining our
UK Personal Care and Beauty businesses. With one combined
leadership team and one 'face to the customer', we anticipate
benefits from greater scale and faster, more efficient
decision-making. We have already seen some benefits emerge as we
combine shelving space at key retailers and leverage the UK
Personal Care commercial execution with Beauty influencer and
digital media expertise.
Secondly, we have taken further
steps to strengthen brand-building team capabilities under Paul
Yocum, previously Managing Director of Business Development, in the
new role of Chief Growth and Marketing Officer. The organisational
changes will lead to greater consolidation of central R&D and
innovation resources which will allow us to
evaluate opportunities more effectively and provide better support
to our Business Units. This will enable us to
leverage the benefits of centralising certain activities
while retaining the local insights our multi-local portfolio
footprint can provide.
Growing sustainably
We are making good progress towards
becoming a more sustainable business. Key achievements in FY24
included:
·
a 42.8% reduction compared to baseline in scopes 1
and 2 carbon emissions (FY23 0.3% reduction);
·
a 9.2% reduction in virgin plastic compared to
baseline (FY23: -7.8%);
and
·
85.6% of packaging is now recyclable, reusable or
compostable (FY23:
84.4%).
We have decided to strengthen our
commitment to sustainability by joining the UN Global Compact, the
largest corporate sustainability initiative in the world. By
becoming a participant, we have committed to aligning our strategy
and operations with the UN's Ten Principles for human rights,
labour, environment, and anti-corruption. We will also commit to
submitting an annual Communication on Progress report.
FY25 priorities
FY25 is set to be a year of
significant change for PZ Cussons. We are specifically focused on
three priorities to support our transformation:
1. drive our
businesses in the UK, ANZ and Indonesia;
2. strengthen our
brand-building capabilities and embed our new operating model;
and
3. deliver the
portfolio transformation to maximise shareholder value.
Overview of Group financial performance
Our FY24 financial performance has
been defined by the material adverse impact of the devaluation of
the Nigerian Naira, which first took place in June 2023. It has
significantly impacted the trading of our Nigeria business and has
caused a deterioration in the Group's balance sheet. A key focus
for the Group throughout the year has therefore been in mitigating
any further impact through strengthening the operations of the
Nigerian business with a focus on profitability and repatriating
cash to the UK - reducing exposure to further devaluation and
allowing us to repay gross borrowings. At the same time, we
continued to invest across the business to ensure delivery against
our strategy.
Revenue declined by 19.6%, impacted
by the Naira devaluation. LFL revenue growth was 4.4%, which
reflected price/mix growth of 6.8% and a volume decline of
2.4%.
Adjusted operating profit declined
by £15.0 million at reported FX rates. Adjusted EPS declined by
28.6% - lower than
the 39.7% decline in adjusted profit before tax due to a reduction
in the Effective Tax Rate and a lower non-controlling
interest. On a statutory basis, the
operating loss was £83.7 million primarily due to the foreign exchange loss of £107.5 million, which arose primarily
on the translation and settlement of USD-denominated liabilities in
our Nigerian subsidiaries following the Naira
devaluation.
Free cash flow was £41.6 million,
which was lower than the prior year's £69.9 million due principally
to lower operating profit and a working capital outflow. Our net
debt was £115.3 million, which represents a material change from
the £5.7 million net cash position in the prior year, driven
largely by the £139.9 million reduction in the value of cash held
in Nigeria due to the devaluation.
Performance by geography
Europe and the Americas (38.0% of
FY24 Group revenue)
£m
unless otherwise stated
|
FY24
|
FY23
|
Growth /
(decline)
|
Revenue
|
200.7
|
205.8
|
(2.5)%
|
LFL revenue growth (%)
|
(1.9)%
|
(0.5)%
|
n/a
|
Adjusted operating profit
|
32.6
|
29.3
|
11.3%
|
Margin (%)
|
16.2%
|
14.2%
|
200bps
|
Operating profit
|
0.7
|
0.4
|
75.0%
|
Margin (%)
|
0.3%
|
0.2%
|
10bps
|
Revenue declined by 1.9% on a
like-for-like basis due to the decline in our Beauty brands, partly
offset by strong growth in our UK Personal Care business. Price/mix
growth was 0.2%, and volume declined by 2.1%.
Our UK Personal Care business,
consisting primarily of Carex, Original Source, and Imperial
Leather has delivered double-digit revenue growth. The UK washing
and bathing category grew 6% in value terms as consumers began to
increase spending following a period of cost-of-living challenges.
Our market share grew 140bps in volume terms with improvements in
all sub-categories [5] and was unchanged on a value
basis. Carex returned to growth for the year as a whole and
delivered improving trends throughout the year, supported by its
successful collaboration with the Gruffalo and the launch of
one-litre refill packs. Original Source revenue grew by over 20%
due to strong campaign activity and increased listings, with
distribution points growing by 12%. We have seen continued success
of the Imperial Leather relaunch, which began in FY22 and which was
supported by the launch of Cussons Creations at a value price
point, with the brands together growing double-digits in FY24.
Cussons Creations was one of the fastest-growing brands in the
Washing and Bathing category. Imperial Leather maintained its
market share with improved packaging, which provided increased
in-store prominence.
In our legacy Beauty business unit,
which consists primarily of St. Tropez, Sanctuary Spa, Fudge, and
Charles Worthington, revenue declined by double-digits. This
decline was primarily driven by St. Tropez, where we experienced
de-stocking from a major customer and slower trading in the US,
driven by overall softer consumer sentiment and poor weather.
Sanctuary Spa's revenue declined in the first half of the year,
reflecting the decision to reduce the Christmas gifting product
portfolio to protect profitability. However, it saw good revenue
growth in the second half of the year.
Childs Farm reported a second full
year of double-digit revenue growth under our ownership. This
growth was driven by continued strong commercial execution, with a
5% increase in distribution points, and ongoing brand strengthening
with awareness improving and a near doubling of social media
followers over the past two years. Together, these elements have
resulted in market share gains.
Despite the reduction in revenue,
adjusted operating profit and margin improved. At 19.5%, the H2
FY24 adjusted operating profit margin is the highest since the
Covid-19 peak in FY21 and was achieved despite a softer performance
from our higher-margin brands such as St. Tropez. This improvement
in adjusted operating margin was primarily driven by our UK
Personal Care business following the strong RGM and cost
initiatives throughout the year. Childs Farm recorded positive
adjusted operating profit, primarily due to improved adjusted gross
profit margin. On a statutory basis, operating profit was £0.7
million, which includes investment in transformation projects and
the impairment of Sanctuary Spa in the first half of the
year.
[5] Source for market growth and share figures: IRI All Outlets
plus Kantar Discounters MAT to 8th June 2024.
Asia Pacific (33.2% of FY24 Group
revenue)
£m
unless otherwise stated
|
FY24
|
FY23
|
Growth /
(decline)
|
Revenue
|
175.2
|
190.7
|
(8.1)%
|
LFL revenue growth (%)
|
(3.4)%
|
4.4%
|
n/a
|
Adjusted operating profit
|
28.0
|
27.5
|
1.8%
|
Margin (%)
|
16.0%
|
14.4%
|
160bps
|
Operating profit
|
27.0
|
29.6
|
(8.8)%
|
Margin (%)
|
15.4%
|
15.5%
|
(10)bps
|
Revenue declined 8.1% due to a
decline in LFL revenue and unfavourable FX, driven by a
depreciation in the Indonesian Rupiah and Australian Dollar. On a
LFL basis, revenue declined 3.4% with consistent growth in ANZ
offset by a decline in Indonesia.
Cussons Baby in Indonesia declined
slightly, reflecting softer consumer sentiment and a reduction in
distributor stock levels throughout much of the year. The business
returned to revenue and market share growth in Q4, however, and
distributor stock at the end of the year had returned to normal
levels. Despite some loss of market share for the year as a whole,
Cussons Baby retained #1 or #2 positions in most of the
sub-categories in which it plays. The launch of Cussons Baby into
the warming oil segment, a category estimated to be used by over
80% of Indonesian mothers, has gone well. We continue to see
meaningful revenue growth opportunities with this
innovation.
ANZ delivered continued solid
growth. This was led by Radiant, up double-digits, resulting in it
becoming the third largest brand in the laundry market (up from
sixth previously). Growth came through both volume and price/mix,
driven by the successful launch of capsules alongside the existing
powder and liquid products. Morning Fresh also performed well,
maintaining its nearly 50% category share. The FY23 launch of the
Morning Fresh auto dishwash range also contributed to revenue,
although its performance has been softer than initially anticipated
due to a strong competitor response. Our long-term ambition to
leverage the significant brand equity of Morning Fresh to extend
'beyond the sink' is unchanged. Rafferty's Garden revenue slightly
declined but market share was stable.
Despite the decline in revenue,
adjusted operating margin grew by 160bps. This was principally due
to a further significant improvement in profitability in ANZ, where
new product innovation has been highly accretive to margins, and
reduced freight costs. Profitability was also improved due to the
reduction in cost associated with our wider manufacturing
operations in Asia, albeit offset by the challenging trading in
Indonesia. On a statutory basis, margins declined by 10bps.
Africa (28.7% of FY24 Group
revenue)
£m
unless otherwise stated
|
FY24
|
FY23
|
Growth /
(decline)
|
Revenue
|
151.7
|
256.3
|
(40.8)%
|
LFL revenue growth (%)
|
26.5%
|
13.4%
|
n/a
|
Adjusted operating profit
|
30.3
|
37.2
|
(18.5)%
|
Margin (%)
|
20.0%
|
14.5%
|
550bps
|
Operating profit
|
(50.7)
|
48.3
|
n.m.
|
Margin (%)
|
(33.4)%
|
18.8%
|
(5,220)bps
|
The results should be seen in light
of the Naira devaluation throughout this year. This devaluation has
created high inflation levels, and we have needed to carry out
nearly 30 rounds of price increases during the year. This has been
a key driver of the 26.5% LFL revenue growth. Volumes declined by
4.7% in FY24, but this trend improved throughout the year. On a
reported basis, revenue declined by 40.8% due to the Naira being
57% lower in FY24 compared to the prior year.
The continued transformation of our
route-to-market has been a major driver of revenue growth in our
Nigerian business and has helped to limit the decline in volumes.
Firstly, we have continued to increase the availability of our
products through expanding the number of stores served directly as
opposed to via wholesalers. We serve approximately 151,000 stores
today - over 50%
higher than at the end of FY23 and more than double the number of
two years ago. Secondly, we have also continued to increase the
number of 'priority' stores -
those which attract greater commercial focus and
are typically supplied with a wider range of products. Thirdly, the
productivity of our existing distribution has increased with vans
and bikes reaching more customer and consumer locations. Our sales
per van have more than doubled, partly due to this increased
efficiency.
As a result of the improved
distribution, the market shares of our key Nigerian brands have
remained largely unchanged despite the significant price increases.
Morning Fresh, however, has seen some share loss due to its pricing
relative to competitor products.
Revenue in our electricals business
grew over 20% on a LFL basis, contributing revenue of £56.6
million. Gross margins declined as price increases did not fully
offset the increased costs resulting from the devaluation of the
Naira. Compared to the rest of our Nigerian business, the
electricals business sees greater input costs denominated in US
Dollars.
The PZ Wilmar joint venture
contributed £10.7 million (FY23:
£7.5 million) to adjusted operating profit. Compared to the
prior year, this improvement reflects continued strong commercial
execution.
Adjusted operating
profit margin grew by 550bps. Profit however included a £8.9
million credit from some intra-Group debt forgiveness, with the
loss being recorded in our Central segment. Excluding this, Africa
adjusted operating profit margin declined by 40bps. On a statutory
basis, we reported an operating loss of £50.7 million, reflecting
the increased value of trade and loan liabilities denominated in US
Dollars.
Other financial items
Adjusted operating profit
Adjusted operating profit for the
Group was £58.3 million, which compares to £73.3 million in the
prior year. The adjusted operating profit margin decreased by 20bps
to 11.0%.
Adjusted gross profit margin
increased by 60bps to 39.8%. This increase primarily reflects the
strong underlying improvement in the Europe and Americas segment.
There was also a favourable currency mix effect as Africa, with
lower margins, represented a smaller proportion of revenue compared
to the prior year as a result of the Naira devaluation. Marketing
investment was reduced slightly in FY24, mainly due to a reduction
in allocation to our UK-based Beauty brands. Central costs
increased by £11.9 million compared to the prior year, but included
a £8.9 million cost related to the cancellation of a debt
previously attributable to our Africa region. PZ Wilmar, our
cooking oils joint venture with Wilmar International, performed
strongly and contributed £10.7 million to operating profit
(FY23: £7.5
million).
Adjusting items
Adjusting items in the year totalled
a net expense of £140.6 million before tax. This related primarily
to a £107.5 million foreign exchange loss arising from the
devaluation of the Nigerian Naira. A charge of £24.4 million was
incurred due to the impairment of the Sanctuary Spa brand in the
first half of the year, and costs of £10.1 million were incurred on
simplification and transformation projects. See Note 3 for further
details on adjusting items.
The devaluation of the Nigerian
Naira has had a significant impact on our financial results and
comparisons to the prior year. The foreign exchange loss of £107.5
million primarily arose from the translation and settlement of
USD-denominated liabilities in our Nigerian subsidiaries and is
wholly the result of the devaluation of the Naira, which fell by
70% from 31 May 2023 to 31 May 2024. See further details on the
Naira rates used in our financial statements in the table on page
13.
After accounting for adjusting
items, the Group's statutory operating loss was £83.7 million,
compared to a statutory operating profit of £59.7 million in the
prior year.
Net finance costs
Adjusted net finance expense was
£13.4 million, compared to income of £0.8 million in the prior
year. This was the result of cash balances in Naira, which earn a
significantly higher rate of interest than that paid on our
sterling-denominated gross borrowings, being significantly lower as
a result of the devaluation.
Taxation
On an adjusted basis, the effective
tax rate was 14.5% (FY23: 27.1%) reflecting the underlying cash tax
impact to Group. The year-on-year reduction was primarily due to a
change in the tax regime operating in Nigeria whereby, for
loss-making businesses, tax is assessed on the basis of revenue
rather than profitability, together with the tax deductibility of
realised FX impacts arising as a result of the cash repatriation
from Nigeria to the UK.
On a reported basis, the tax credit
for the year was £24.1 million compared to a tax charge of £15.4
million in the prior year. The effective tax rate for the year is
25.0% (2023: 24.9%).
Earnings per share
Adjusted basic earnings per share
was 8.02p compared to 11.23p in the prior year. The statutory loss
for the year was £71.8 million, compared to a profit of £46.4
million in the prior year. Basic loss per share on a statutory
basis was 13.60p compared to basic earnings per share of 8.70p in
the prior year.
Balance sheet and cash flow
As at 31 May 2024, cash and cash
equivalents were £51.3 million (FY23: £256.4 million). The decrease
was driven principally by a £139.9 million reduction in the value
of cash held in Nigeria due to the devaluation and the repayment of
gross debt. The reduction in net assets from £422.1 million to
£235.2 million is primarily the result of losses relating to the
devaluation of the Naira and a £24.4 million impairment of the
Sanctuary Spa brand, partly offset by the Group's underlying net
profit.
The Group has a £325 million
committed credit facility available for general corporate purposes.
The credit facility incorporates a term loan of up to £125 million,
with the balance as a revolving credit facility ('RCF') structure
with maturity dates up to November 2028. As at 31 May 2024, this
facility was £161.0 million drawn (FY23: £252.0
million).
Free cash flow was £41.6 million.
This was lower than the prior year's £69.9 million due principally
to lower operating profit and a working capital outflow.
£m
unless otherwise stated
|
|
FY24
|
FY23
|
Adjusted EBITDA
|
|
75.9
|
92.4
|
Cash flow impact of adjusting
items
|
|
(12.1)
|
(14.6)
|
Working capital movements
[6]
|
|
(9.4)
|
4.1
|
Capex
|
|
(6.1)
|
(6.7)
|
Share of JV results
|
|
(10.7)
|
(7.5)
|
Other
|
|
4.0
|
2.2
|
Free cash flow
|
|
41.6
|
69.9
|
Dividend
The Board announces its intention to
declare an interim dividend of 2.1p per share, down 44% compared to
last year's final dividend of 3.73p. This represents a full year
dividend of 3.6p which is also down 44%, reflecting the impact of
the Naira devaluation on earnings per share while maintaining an
earnings cover of approximately two
times.
The dividend will be paid on 4
December 2024 to shareholders on the register at the close of
business on 1 November 2024.
Foreign exchange: impact on FY24 results
The devaluation of the Naira
resulted in a £130.6 million adverse impact on year-on-year revenue
in FY24 when translated into Sterling. Outside of Nigeria, the
general strengthening of Sterling against other currencies resulted
in a £19.3 million reduction in FY24 revenue compared to
FY23.
|
% of FY24
revenue
|
Average FX
rates
|
Revenue impact
(£m)
|
FY23
|
FY24
|
GBP
|
34%
|
1.0
|
1.0
|
-
|
NGN
|
24%
|
536.3
|
1,256.7
|
(130.6)
|
AUD
|
17%
|
1.8
|
1.9
|
(6.7)
|
IDR
|
12%
|
18,174.2
|
19,549.7
|
(5.3)
|
USD
|
6%
|
1.2
|
1.3
|
(1.9)
|
Other
|
7%
|
-
|
-
|
(5.4)
|
Total[7]
|
100%
|
-
|
-
|
(149.9)
|
Foreign exchange: impact on future results
Given the materiality of the
movement in the Nigerian Naira in recent periods, the rates used in
recent reporting periods are summarised below. The currency
devalued by 70% from 31 May 2023 to 31 May 2024, and was on average
57% lower for the financial year as a whole. The Naira has
continued to weaken in FY25.
NGN/GBP
|
FY22
|
FY23
|
FY24
|
Q1
FY25[8]
|
Rate used for P&L
|
558
|
536
|
1,256
|
1,979
|
Rate used for balance
sheet
|
530
|
577
|
1,893
|
2,100
|
[6] Working capital
movements of £9.4 million reflect £94.7 million inflow per cash
flow statement, adjusted for £104.1 million FX losses arising on
Nigerian Naira devaluation.
[7] Table shows the impact of translating FY23 revenue at FY24
foreign exchange rates.
[8] P&L rate represents average rates between 1 June and 31
August (Q1 FY25) and balance sheet rate is as at 31
August.
|
|
APM
|
Alternative performance
measure.
|
BEST
values
|
Our PZ Cussons values (Bold,
Energetic, Striving and Together).
|
Brand Investment
|
An operating cost related to brand
marketing (previously 'Media & Consumer').
|
EBITDA
|
Earnings before interest, taxes,
depreciation and amortisation.
|
Employee well-being
|
% score based upon a set of questions
within our annual survey of employees.
|
EPS
|
Earnings per share.
|
ETR
|
Effective tax rate.
|
ExCo
|
Executive Committee
|
Family Care
|
Refers to our Hygiene, Baby and
Beauty brands in Nigeria and Africa.
|
Free
cash flow
|
Cash generated from operations less
capital expenditure.
|
Free
cash flow conversion
|
Free cash flow as a % of adjusted
EBITDA from continuing operations.
|
Like
for like ('LFL') revenue growth
|
Growth on the prior year at constant
currency, excluding unbranded sales and the impact of disposals and
acquisitions, and adjusting for the number of reporting days in the
period.
|
Must
Win Brands
|
The brands in which we place greater
investment and focus. They comprise: Carex, Childs Farm (acquired
in March 2022), Cussons Baby, Joy, Morning Fresh, Original Source,
Premier, Sanctuary Spa and St. Tropez.
|
Net
debt
|
Cash, short-term deposits and current
asset investments, less bank overdrafts and borrowings. Excludes
IFRS 16 lease liabilities.
|
Personal Care
|
Refers to our UK business unit
operating our Hygiene brands such as Carex, Original Source and
Imperial Leather.
|
Portfolio Brands
|
The brands we operate which are not
Must Win Brands.
|
PZ
Cussons Growth Wheel
|
Our 'repeatable model' for driving
commercial execution, comprising 'Consumability', 'Attractiveness',
'Shopability' and 'Memorability'.
|
Revenue Growth Management ('RGM')
|
Maximising revenue through ensuring
optimised price points across customers and channels and across
different product sizes.
|
SKUs
|
Stock keeping unit.
|
Through the Line
|
Marketing campaign incorporating both
mass reach and targeted activity.
|
Alternative Performance Measures
|
2024
|
2023
|
|
Business performance
excluding adjusting items
|
Adjusting
items
|
Statutory
results
|
Business
performance excluding adjusting items
|
Adjusting
items
|
Statutory
results
|
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
Revenue
|
527.9
|
-
|
527.9
|
656.3
|
-
|
656.3
|
Cost of sales
|
(317.8)
|
(79.0)
|
(396.8)
|
(399.0)
|
-
|
(399.0)
|
|
|
|
|
|
|
|
Gross profit
|
210.1
|
(79.0)
|
131.1
|
257.3
|
-
|
257.3
|
Selling and distribution
expense
|
(82.8)
|
-
|
(82.8)
|
(105.3)
|
-
|
(105.3)
|
Administrative expense
|
(79.7)
|
(59.6)
|
(139.3)
|
(86.2)
|
(13.6)
|
(99.8)
|
Share of results of joint
venture
|
10.7
|
(3.4)
|
7.3
|
7.5
|
-
|
7.5
|
Operating
profit/(loss)
|
58.3
|
(142.0)
|
(83.7)
|
73.3
|
(13.6)
|
59.7
|
|
|
|
|
|
|
|
Finance income
|
10.8
|
1.4
|
12.2
|
14.1
|
1.3
|
15.4
|
Finance expense
|
(24.2)
|
-
|
(24.2)
|
(13.3)
|
-
|
(13.3)
|
Net
finance (expense)/income
|
(13.4)
|
1.4
|
(12.0)
|
0.8
|
1.3
|
2.1
|
|
|
|
|
|
|
|
Net monetary loss arising from
hyperinflationary economies
|
(0.2)
|
-
|
(0.2)
|
-
|
-
|
-
|
Profit/(loss) before taxation
|
44.7
|
(140.6)
|
(95.9)
|
74.1
|
(12.3)
|
61.8
|
Taxation
|
(6.5)
|
30.6
|
24.1
|
(20.1)
|
4.7
|
(15.4)
|
|
|
|
|
|
|
|
Profit/(loss) for the period
|
38.2
|
(110.0)
|
(71.8)
|
54.0
|
(7.6)
|
46.4
|
|
|
|
|
|
|
|
Attributable to:
|
|
|
|
|
|
|
Owners of the Parent
|
33.6
|
(90.6)
|
(57.0)
|
47.0
|
(10.6)
|
36.4
|
Non-controlling interests
|
4.6
|
(19.4)
|
(14.8)
|
7.0
|
3.0
|
10.0
|
|
38.2
|
(110.0)
|
(71.8)
|
54.0
|
(7.6)
|
46.4
|
The Group's business performance is
assessed using a number of Alternative Performance Measures
('APMs'). These APMs include adjusted profitability measures where
results are presented excluding separately disclosed items
(referred to as adjusting items) as we believe this provides both
management and investors with useful additional information about
the Group's performance and supports a more effective comparison of
the Group's trading performance from one period to the next. Like
for like ('LFL') revenue growth represents the growth on the prior
year, adjusting for constant currency and excluding the impact of
disposals and acquisitions.
Adjusted Consolidated Income Statement
Details of adjusting items are
provided in Note 3 to the condensed consolidated financial
statements. Reconciliations from IFRS reported results to APMs are
set out below.
Alternative Performance Measures (continued)
Adjusted operating profit and adjusted operating
margin
|
|
2024
|
2023
|
|
|
£m
|
£m
|
Group
|
|
|
|
Operating (loss)/profit from
continuing operations
|
|
(83.7)
|
59.7
|
Exclude: adjusting items
|
|
142.0
|
13.6
|
Adjusted operating profit
|
|
58.3
|
73.3
|
|
|
|
|
Revenue
|
|
527.9
|
656.3
|
Operating margin
|
|
-15.9%
|
9.1%
|
Adjusted operating margin
|
|
11.0%
|
11.2%
|
|
|
|
|
By
segment
|
|
|
|
Europe & the
Americas:
|
|
|
|
Operating (loss)/profit from
continuing operations
|
|
0.7
|
0.4
|
Exclude: adjusting items
|
|
31.9
|
28.9
|
Adjusted operating profit
|
|
32.6
|
29.3
|
|
|
|
|
Revenue
|
|
200.7
|
205.8
|
Operating margin
|
|
0.3%
|
0.2%
|
Adjusted operating margin
|
|
16.2%
|
14.2%
|
|
|
|
|
Asia Pacific:
|
|
|
|
Operating profit from continuing
operations
|
|
27.0
|
29.6
|
Exclude: adjusting items
|
|
1.0
|
(2.1)
|
Adjusted operating profit
|
|
28.0
|
27.5
|
|
|
|
|
Revenue
|
|
175.2
|
190.7
|
Operating margin
|
|
15.4%
|
15.5%
|
Adjusted operating margin
|
|
16.0%
|
14.4%
|
|
|
|
|
Africa:
|
|
|
|
Operating (loss)/profit from
continuing operations
|
|
(50.7)
|
48.3
|
Exclude: adjusting items
|
|
81.0
|
(11.1)
|
Adjusted operating profit
|
|
30.3
|
37.2
|
|
|
|
|
Revenue
|
|
151.7
|
256.3
|
Operating margin
|
|
-33.4%
|
18.8%
|
Adjusted operating margin
|
|
20.0%
|
14.5%
|
|
|
|
|
Central:
|
|
|
|
Operating loss from continuing
operations
|
|
(60.7)
|
(18.6)
|
Exclude: adjusting items
|
|
28.1
|
(2.1)
|
Adjusted operating loss
|
|
(32.6)
|
(20.7)
|
Alternative Performance Measures (continued)
Adjusted gross profit
|
|
2024
|
2023
|
|
|
£m
|
£m
|
Gross profit
|
|
131.1
|
257.3
|
Exclude: adjusting items
|
|
79.0
|
-
|
Adjusted gross profit
|
|
210.1
|
257.3
|
|
|
|
|
Revenue
|
|
527.9
|
656.3
|
Gross margin
|
|
24.8%
|
39.2%
|
Adjusted gross margin
|
|
39.8%
|
39.2%
|
Adjusted share of results of joint venture
|
|
2024
|
2023
|
|
|
£m
|
£m
|
Share of results of joint
venture
|
|
7.3
|
7.5
|
Exclude: adjusting items
|
|
3.4
|
-
|
Adjusted share of results of joint
venture
|
|
10.7
|
7.5
|
Adjusted profit before taxation
|
|
2024
|
2023
|
|
|
£m
|
£m
|
(Loss)/profit before taxation from
continuing operations
|
|
(95.9)
|
61.8
|
Exclude: adjusting items
|
|
140.6
|
12.3
|
Adjusted profit before
taxation
|
|
44.7
|
74.1
|
Adjusted Earnings Before Interest Depreciation and
Amortisation (Adjusted EBITDA)
|
|
2024
|
2023
|
|
|
£m
|
£m
|
(Loss)/profit before taxation from
continuing operations
|
|
(95.9)
|
61.8
|
Add back/(deduct): net finance
expense/(income)
|
|
12.0
|
(2.1)
|
Add back: depreciation
|
|
10.2
|
12.1
|
Add back: amortisation
|
|
7.1
|
7.0
|
Add back: impairment and impairment
reversal
|
|
24.9
|
12.3
|
|
|
(41.7)
|
91.1
|
Exclude: adjusting items*
|
|
117.6
|
1.3
|
Adjusted EBITDA
|
|
75.9
|
92.4
|
* Excludes adjusting items relating
to impairment.
Alternative Performance Measures (continued)
Adjusted earnings per share
|
2024
|
2023
|
|
£m
|
£m
|
(Loss)/profit after tax attributable to owners of the
Parent
|
(57.0)
|
36.4
|
Exclude: adjusting items (net of
taxation effect)
|
90.6
|
10.6
|
Adjusted profit after taxation
|
33.6
|
47.0
|
|
2024
|
2023
|
|
pence
|
pence
|
Basic (loss)/earnings per share
|
(13.60)
|
8.70
|
Exclude: adjusting items
|
21.62
|
2.53
|
Adjusted basic earnings per share
|
8.02
|
11.23
|
Diluted (loss)/earnings per
share1
|
(13.60)
|
8.67
|
Exclude: adjusting
items2
|
21.60
|
2.52
|
Adjusted diluted earnings per share
|
8.00
|
11.19
|
1 In 2024, the basic and diluted loss per share are equal as a
result of the Group incurring a loss for the
year.
2 In 2024, this includes an adjustment of 0.03 pence per share
arising from bringing the diluted loss per share in line with the
basic loss per share as outlined above).
Free cash flow
|
|
2024
|
2023
|
|
|
£m
|
£m
|
Cash generated from
operations
|
|
47.7
|
76.6
|
Deduct: purchase of property, plant
and equipment and software
|
|
(6.1)
|
(6.7)
|
Free cash flow
|
|
41.6
|
69.9
|
CONDENSED CONSOLIDATED INCOME STATEMENT
|
|
2024
|
2023
|
|
Notes
|
£m
|
£m
|
Revenue
|
|
527.9
|
656.3
|
Cost of sales
|
|
(396.8)
|
(399.0)
|
|
|
|
|
Gross profit
|
|
131.1
|
257.3
|
Selling and distribution
expense
|
|
(82.8)
|
(105.3)
|
Administrative expense
|
|
(139.3)
|
(99.8)
|
Share of results of joint
venture
|
|
7.3
|
7.5
|
Operating
(loss)/profit
|
|
(83.7)
|
59.7
|
|
|
|
|
Finance income
|
|
12.2
|
15.4
|
Finance expense
|
|
(24.2)
|
(13.3)
|
Net
finance (expense)/income
|
|
(12.0)
|
2.1
|
|
|
|
|
Net monetary loss arising from
hyperinflationary economies3
|
|
(0.2)
|
-
|
(Loss)/profit before taxation
|
|
(95.9)
|
61.8
|
Taxation
|
4
|
24.1
|
(15.4)
|
|
|
|
|
(Loss)/profit for the year1
|
|
(71.8)
|
46.4
|
|
|
|
|
|
|
|
|
Attributable to:
|
|
|
|
Owners of the Parent
|
|
(57.0)
|
36.4
|
Non-controlling interests
|
|
(14.8)
|
10.0
|
|
|
(71.8)
|
46.4
|
(Loss)/earnings per ordinary
share1
|
|
|
|
Basic (p)
|
6
|
(13.60)
|
8.70
|
Diluted (p)2
|
6
|
(13.60)
|
8.67
|
|
|
|
|
1 Wholly derived from
continuing operations.
2 In 2024, the basic and
diluted loss per share are equal as a result of the Group incurring
a loss for the year.
3 Represents the
hyperinflation impact in relation to
Ghana.
CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE
INCOME
|
|
2024
|
2023
|
|
Notes
|
£m
|
£m
|
(Loss)/profit for the year
|
|
(71.8)
|
46.4
|
Other comprehensive
(expense)/income:
|
|
|
|
Items that will not be reclassified to income
statement:
|
|
|
|
Re-measurement loss on net
retirement benefit obligations
|
|
(6.8)
|
(32.8)
|
Taxation on other comprehensive
income
|
|
1.7
|
7.4
|
Total items that will not be reclassified to income
statement
|
|
(5.1)
|
(25.4)
|
|
|
|
|
Items that may be subsequently reclassified to income
statement:
|
|
|
|
Exchange differences on translation
of foreign operations1
|
|
(69.4)
|
(19.6)
|
Share of other comprehensive expense
of joint venture accounted for using the equity method
|
|
(20.0)
|
(2.1)
|
Cash flow hedges - fair value
movements net of amounts reclassified
|
|
(0.6)
|
0.4
|
Total items that may be subsequently reclassified to income
statement
|
|
(90.0)
|
(21.3)
|
Other comprehensive expense for the year
|
|
(95.1)
|
(46.7)
|
Total comprehensive expense for the year
|
|
(166.9)
|
(0.3)
|
|
|
|
|
Attributable to:
|
|
|
|
Owners of the Parent
|
|
(133.3)
|
(6.9)
|
Non-controlling interests
|
|
(33.6)
|
6.6
|
|
|
(166.9)
|
(0.3)
|
1 Includes a hyperinflation
adjustment of £4.3 million (2023: £nil) in relation to Ghana, net
of £1.3m deferred taxation.
CONDENSED CONSOLIDATED BALANCE SHEET
|
|
2024
|
2023
|
|
Notes
|
£m
|
£m
|
Assets
|
|
|
|
Non-current assets
|
|
|
|
Goodwill and other intangible
assets
|
7
|
279.3
|
312.7
|
Property, plant and
equipment
|
|
42.8
|
67.9
|
Investment properties
|
|
6.6
|
6.4
|
Right-of-use assets
|
|
10.2
|
12.5
|
Net investments in joint
venture
|
|
-
|
52.0
|
Trade and other
receivables
|
|
32.1
|
-
|
Deferred taxation assets
|
|
22.2
|
7.5
|
Current tax receivable
|
|
0.6
|
-
|
Retirement benefit
surplus
|
|
32.1
|
38.5
|
|
|
425.9
|
497.5
|
Current assets
|
|
|
|
Inventories
|
|
68.5
|
112.9
|
Trade and other
receivables
|
|
99.0
|
119.1
|
Derivative financial
assets
|
|
-
|
1.0
|
Current tax receivable
|
|
0.2
|
1.0
|
Current asset investments
|
|
-
|
0.5
|
Cash and cash equivalents
|
8
|
51.3
|
256.4
|
|
|
219.0
|
490.9
|
Assets held for sale
|
|
4.7
|
-
|
|
|
223.7
|
490.9
|
Total assets
|
|
649.6
|
988.4
|
Equity and liabilities
|
|
|
|
Equity
|
|
|
|
Share capital
|
|
4.3
|
4.3
|
Own shares
|
|
(34.5)
|
(36.9)
|
Capital redemption
reserve
|
|
0.7
|
0.7
|
Hedging reserve
|
|
(0.4)
|
0.2
|
Currency translation
reserve
|
|
(159.6)
|
(89.0)
|
Retained earnings
|
|
425.3
|
511.7
|
Other reserves
|
|
6.5
|
4.6
|
Attributable to owners of the Parent
|
|
242.3
|
395.6
|
Non-controlling interests
|
|
(7.1)
|
26.5
|
Total equity
|
|
235.2
|
422.1
|
Liabilities
|
|
|
|
Non-current liabilities
|
|
|
|
Borrowings
|
8
|
160.3
|
251.2
|
Other payables
|
|
2.6
|
4.1
|
Lease liabilities
|
|
9.7
|
11.3
|
Deferred taxation
liabilities
|
|
39.8
|
76.9
|
Retirement and other long-term
employee benefit obligations
|
|
12.2
|
12.4
|
|
|
224.6
|
355.9
|
Current liabilities
|
|
|
|
Borrowings
|
8
|
6.3
|
-
|
Trade and other payables
|
|
158.7
|
182.2
|
Lease liabilities
|
|
2.4
|
1.7
|
Derivative financial
liabilities
|
|
0.5
|
0.5
|
Current taxation payable
|
|
21.7
|
25.6
|
Provisions
|
|
0.2
|
0.4
|
|
|
189.8
|
210.4
|
Total liabilities
|
|
414.4
|
566.3
|
Total equity and liabilities
|
|
649.6
|
988.4
|
|
|
|
|
CONDENSED CONSOLIDATED CASH FLOW
STATEMENT
|
|
2024
|
2023
|
|
Notes
|
£m
|
£m
|
Cash flows from operating activities
|
|
|
|
Cash generated from
operations
|
9
|
47.7
|
76.6
|
Interest paid
|
|
(21.5)
|
(11.8)
|
Taxation paid
|
|
(13.3)
|
(15.6)
|
Net
cash generated from/(used in) operating activities
|
|
12.9
|
49.2
|
|
|
|
|
Cash flows from investing activities
|
|
|
|
Interest received
|
|
9.0
|
11.8
|
Purchase of property, plant and
equipment and software
|
|
(6.1)
|
(6.7)
|
Proceeds from disposal of property,
plant and equipment
|
|
0.8
|
14.4
|
Loans advanced to joint
venture
|
|
(4.0)
|
(11.2)
|
Loans repaid by joint
venture
|
|
12.7
|
11.2
|
Net
cash generated from investing activities
|
|
12.4
|
19.5
|
|
|
|
|
Cash flows from financing activities
|
|
|
|
Dividends paid to Company
shareholders
|
8
|
(21.9)
|
(26.8)
|
Dividends paid to non-controlling
interests
|
|
-
|
(2.6)
|
Repayment of lease
liabilities
|
|
(2.4)
|
(2.5)
|
Repayment of borrowings
|
10
|
(206.0)
|
(205.0)
|
Proceeds from borrowings
|
10
|
121.4
|
283.0
|
Financing fees paid on committed
credit facility
|
|
(0.8)
|
(2.8)
|
Net
cash (used in)/generated from financing
activities
|
|
(109.7)
|
43.3
|
|
|
|
|
Net
increase in cash and cash equivalents
|
10
|
(84.4)
|
112.0
|
Effect of foreign exchange
rates
|
10
|
(120.7)
|
(19.3)
|
Cash and cash equivalents at the
beginning of the period/year
|
10
|
256.4
|
163.7
|
Cash and cash equivalents at the end of the
period/year
|
10
|
51.3
|
256.4
|
1. Basis of
preparation
PZ Cussons plc (the 'Company') is a
public limited company incorporated in England and Wales. In these
condensed consolidated financial statements (financial statements),
'Group' means the Company and all its
subsidiaries. The financial information
herein has been prepared on the basis of the accounting policies as
set out in the Annual Report and Accounts of the Group for the year
ended 31 May 2024. The Group has prepared its accounts in
accordance with international accounting standards in conformity
with the requirements of the Companies Act 2006 and International
Financial Reporting Standards (IFRSs) adopted by the UK (UK-adopted
International Accounting Standards) and IFRSs, as issued by the
IASB, including interpretations issued by the IFRS Interpretations
Committee. IFRS as adopted by the UK differs in certain respects
from IFRS as issued by the IASB. The differences have no impact on
the Group's consolidated financial statements for the years
presented.
The preparation of financial
statements requires management to make judgements, estimates and
assumptions that affect the application of accounting policies and
the reported amounts of assets and liabilities, income and expense.
Actual results may differ from these estimates.
In preparing these financial
statements, the significant judgements made by management in
applying the Group's accounting policies and the key sources of
estimation uncertainty were the same as those that applied to the
annual consolidated financial statements for the year ended 31 May
2023 which are described in Note 1(d) of the 2023 Annual Report and
Accounts with the addition of deferred taxation assets:
Deferred taxation assets
Deferred taxation is provided on
temporary differences between the carrying amounts of assets and
liabilities recognised for financial reporting purposes and the
amounts used for taxation purposes, on an undiscounted basis. The
amount of deferred taxation provided is based on the expected
manner of realisation or settlement of the carrying amounts of
assets and liabilities, using tax rates enacted or substantively
enacted at the financial year-end date.
A deferred taxation asset is
recognised only to the extent that it is probable that future
taxable profits will be available against which the asset can be
utilised. Deferred taxation assets are recognised for unused tax
losses to the extent that it is probable that future taxable
profits will be available against which they can be used. At 31 May
2024, the Group recorded a deferred taxation asset of £36.8 million
(2023: £3.6 million) on recognised but unused tax losses; the
increase being largely due to FX losses arising as a result of the
Nigerian Naira devaluation. The Group has concluded that the
deferred taxation assets will be recoverable as it is probable that
the related taxation benefit will be realised in the foreseeable
future.
Going concern
The Group's business activities,
together with the factors likely to affect its future development,
performance and position are set out in the Strategic Report. The
financial position of the Group, liquidity position and
available borrowing facilities are described within the Financial
Review. In addition, note 19 of the Consolidated Financial
Statements includes policies in relation to the Group's financial
instruments and risk management and policies for managing credit
risk, liquidity risk, market risk, foreign exchange risk, price
risk, cash flow and interest rate risk and capital risk.
The Group meets its funding
requirements through internal cash generation and borrowings.
Borrowings are amounts drawn under both committed and uncommitted
borrowing facilities. The Group has a £325.0 million committed
credit facility which is available for general corporate purposes.
As at 31 May 2024, the Group had headroom on the committed facility
of £164.0 million and net debt of £115.3 million comprising cash of
£51.3 million and borrowings of £166.6 million.
In assessing going concern, the Group
has prepared both base case and severe but plausible cash flow
forecasts for a period of 18 months until the end of November 2026
(the "going concern review period"), which is at least 12 months
from the date of approval of the financial statements. The Group's
base case forecasts are based on the Board-approved budget and the
first year of the current five-year plan, and indicate forecasted
continued compliance with its banking covenants and sufficient
liquidity throughout the going concern review period.
The Directors have considered a
severe but plausible downside scenario (excluding the uncertainty
regarding the Nigerian Naira) which models the following
assumptions:
· 5%
reduction in Group revenue; and
· Group
gross margin decline of 200bps.
This downside scenario also shows
both continued compliance with its banking covenants and sufficient
liquidity throughout the going concern review period.
However, over the past year there
have been significant fluctuations in the Naira exchange rate
which, due to the size of the Group's operations in Nigeria, needs
to be considered as part of our going concern assessment. The
Directors have therefore considered an additional severe but
plausible downside Naira exchange rate scenario to stress test the
Group's financial forecasts, using a Naira exchange rate decline of
greater than 10% from the rate as at the start of September 2024.
This unmitigated downside scenario shows a potential breach of the
interest cover financial covenant as at 29 November 2024 which if
management mitigation actions proved insufficient, would result in
the Group needing to negotiate a waiver of its interest cover
covenant to ensure the business meets its borrowing facility
obligations over the going concern review period as the committed
credit facility may become repayable on demand. The Directors are
satisfied that this unmitigated downside scenario does not
potentially breach any of the Group's other financial
covenants.
Management consider there to be
significant and feasible mitigations in place. These include both
short-term and structural cost reductions, as well as the potential
disposal of non-core, non-operating assets. Although
management acknowledges that certain of these mitigations are
outside their control in the very short term, a number of
these mitigating actions are already underway.
The Group is currently engaged in a
process to sell its St Tropez brand and is exploring potential
transactions that could lead to a partial or full sale of its
Africa business, having received a number of expressions of
interest. A partial or full sale of the Group's Africa business
could materially reduce the Group's exposure to fluctuations in the
Naira exchange rate. The Board has committed to using any proceeds
from these transactions to first reduce gross borrowings, and
consequently the level of the Group's net interest cost.
After reviewing the current
liquidity position, financial forecasts, stress testing of
potential risks and considering the uncertainties described above,
and based on the current funding facilities, the Directors expect
the Group to have the financial resources to continue to operate
the business for the foreseeable future. For these reasons, the
Directors continue to adopt the going concern basis of accounting
in preparing the Group financial statements. However, should
management mitigations prove insufficient, the impact of
Naira exchange rate volatility on forecast interest cover covenant
compliance represents a material uncertainty that may cast
significant doubt upon the Group's ability to continue as a going
concern. The financial statements do not include the adjustments
that would result if the Group were unable to continue as a going
concern.
The principal risks which the Group
is exposed to will be disclosed in the Group's 2024 Annual Report
and Accounts. These are: IT and information security; talent
development and retention; macroeconomic and financial volatility
including foreign exchange; consumer and customer trends; legal and
regulatory compliance; business transformation; geopolitical
instability; consumer safety; sustainability and the environment;
and supply chain and logistics.
Certain business units have a
degree of seasonality with the biggest factors being the weather
and Christmas. However, no individual reporting segment is seasonal
as a whole and therefore no further analysis is
provided.
The financial information contained
in this document does not constitute statutory financial statements
as defined in sections 434 and 435 of the Companies Act 2006 for
the years ended 31 May 2024 or 2023 but is derived from these
accounts. Full audited statutory accounts
of the Group in respect of the year ended 31 May 2023 have been
delivered to the Registrar of Companies and those for 2024 will
follow in due course. The report of the auditors on those statutory
accounts was unqualified and did not contain a statement under
section 498 of the Companies Act 2006.
New and amended accounting standards adopted by the
Group
The following amended standards and
interpretations were adopted by the Group during the year ending 31
May 2024:
· Deferred Tax related to Assets and Liabilities arising from a
Single Transaction (Amendments to IAS 12 Income Taxes)
· Disclosure of Accounting Policies (Amendments to IAS 1
Presentation of Financial Statements and IFRS Practice Statement
2)
· Definition of Accounting Estimates (Amendments to IAS 8
Accounting Policies, Changes in Accounting Estimates and
Errors)
· IFRS
17 Insurance
Contracts
These amended standards and
interpretations have not had a significant impact on the
consolidated Financial Statements.
Deferred Tax related to Assets and
Liabilities arising from a Single Transaction - Amendment to IAS 12
narrows the scope of the initial recognition exemption to exclude
transactions that give rise to equal and offsetting temporary
differences such as leases.
The Group previously accounted for
deferred taxation on leases where the deferred taxation asset or
liability was recognised on a net basis. Following the amendments,
the Group has recognised a separate deferred taxation asset in
relation to its lease liabilities and a deferred taxation liability
in relation to its right-of-use assets. However, there is no impact
on the balance sheet because the balances qualify for offset under
paragraph 74 of IAS 12. There was also no impact on the opening
retained earnings as at 1 June 2023 as a result of the
change.
The policy for recognising and
measuring income taxes is consistent with that applied in the
comparative years except for the changes outlined above as a result
of the Group's adoption of the amendments to IAS 12.
On 23 May 2023, the International
Accounting Standards Board issued International Tax Reform Pillar
Two Model Rules - Amendments to IAS 12. The Group has applied the
mandatory temporary exception to the accounting for deferred
taxation arising from the jurisdictional implementation of the
Pillar Two rules set out therein.
New accounting standards and interpretations in issue but not
yet effective
The following new and amended
standards are effective for annual periods beginning on or after 1
January 2024. The Group has not early
adopted the new or amended
standards, where applicable, in preparing these consolidated
Financial Statements.
· Classification of Liabilities as Current or Non-current
(Amendments to IAS 1 Presentation
of financial statements)
· Lease
Liability in a Sale and Leaseback (Amendments to IFRS 16
Leases)
· Supplier financing arrangements (Amendments to IAS 7
Statement of cash flows
and IFRS 7 Financial
instruments)
· Lack
of exchangeability (Amendments to IAS 21 The effects of changes in foreign exchange
rates)
· IFRS
18 Presentation and Disclosure in
Financial Statements
· Amendment to IFRS 9 and IFRS 7 (Classification and Measurement
of Financial Instruments)
These amendments are not expected
to have a material impact on the Group in the current or future
reporting periods, except for the amendments of IAS 21 which may
have a material impact on the financial position or performance of
the Group, but this impact cannot currently be estimated reliably
due to the uncertainty linked to the Nigerian Naira.
Presentation changes
The following changes have been
made to the presentation of the Group's consolidated financial
statements:
· Investment properties are reported separately on the face of
the balance sheet and in the notes rather than being reported as
part of Property, plant and equipment.
· Share
of other comprehensive income of joint venture presented separately
on the face of the Statement of Other Comprehensive
Income.
These are presentation changes and
have no impact on the accounting policies adopted by the
Group.
2. Segmental analysis
The segmental information presented
in this note is consistent with management reporting provided to
the Executive Committee (ExCo) (formerly Executive Leadership Team
(ELT)), which is the Chief Operating Decision Maker (CODM). The
CODM reviews the Group's internal reporting in order to assess
performance and allocate resources and has determined the operating
segments based on these reports. The CODM considers the business
from a geographic perspective, with Europe & the Americas, Asia
Pacific and Africa being the operating segments. In accordance with
IFRS 8 Operating Segments, the ExCo
has identified these as the reportable segments.
The CODM assesses the performance
based on operating profit before any adjusting items. Revenues and
operating profit of the Europe & the Americas and Asia Pacific
segments arise from the sale of Hygiene, Beauty and Baby products.
Revenue and operating profit from the Africa segment also arise
from the sale of Hygiene, Beauty and Baby products as well as
Electrical products. The prices between Group companies for
intra-group sales of materials, manufactured goods, and charges for
franchise fees and royalties are on an arm's length
basis.
Central includes expenditure
associated with the global headquarters and above market functions
net of recharges to our regions and our in-house fragrance house
revenue.
Reporting used by the CODM to assess
performance does contain information about brand specific
performance, however global segmentation between the portfolio of
brands is not part of the regular internally reported financial
information.
Business segments
2024
|
Europe
& the
Americas
£m
|
Asia
Pacific
£m
|
Africa
£m
|
Central
£m
|
Elimin-ations
£m
|
Total
£m
|
Gross segment revenue
|
204.1
|
179.2
|
151.7
|
34.2
|
(41.3)
|
527.9
|
Inter segment revenue
|
(3.4)
|
(4.0)
|
-
|
(33.9)
|
41.3
|
-
|
Revenue
|
200.7
|
175.2
|
151.7
|
0.3
|
-
|
527.9
|
Segmental operating profit/(loss)
before adjusting items and share of results of joint
ventures
|
32.6
|
28.0
|
19.6
|
(32.6)
|
-
|
47.6
|
Share of results of joint
ventures
|
-
|
-
|
10.7
|
-
|
-
|
10.7
|
Segmental operating profit/(loss) before adjusting
items
|
32.6
|
28.0
|
30.3
|
(32.6)
|
-
|
58.3
|
Adjusting Items
|
(31.9)
|
(1.0)
|
(81.0)
|
(28.1)
|
-
|
(142.0)
|
Segmental operating (loss)/profit
|
0.7
|
27.0
|
(50.7)
|
(60.7)
|
-
|
(83.7)
|
Finance income
|
|
|
|
|
|
12.2
|
Finance expense
|
|
|
|
|
|
(24.2)
|
Net monetary loss arising from
hyperinflationary economies
|
|
|
|
|
|
(0.2)
|
Loss
before taxation
|
|
|
|
|
|
(95.9)
|
2. Segmental analysis
(continued)
2023
|
Europe
& the
Americas
£m
|
Asia
Pacific
£m
|
Africa
£m
|
Central
£m
|
Elimin-ations
£m
|
Total
£m
|
Gross segment revenue
|
210.2
|
197.8
|
256.3
|
74.0
|
(82.0)
|
656.3
|
Inter segment revenue
|
(4.4)
|
(7.1)
|
-
|
(70.5)
|
82.0
|
-
|
Revenue
|
205.8
|
190.7
|
256.3
|
3.5
|
-
|
656.3
|
Segmental operating profit before
adjusting items and share of results of joint ventures
|
29.3
|
27.5
|
29.7
|
(20.7)
|
-
|
65.8
|
Share of results of joint
ventures
|
-
|
-
|
7.5
|
-
|
-
|
7.5
|
Segmental operating profit/(loss) before adjusting
items
|
29.3
|
27.5
|
37.2
|
(20.7)
|
-
|
73.3
|
Adjusting Items
|
(28.9)
|
2.1
|
11.1
|
2.1
|
-
|
(13.6)
|
Segmental operating profit/(loss)
|
0.4
|
29.6
|
48.3
|
(18.6)
|
-
|
59.7
|
Finance income
|
|
|
|
|
|
15.4
|
Finance expense
|
|
|
|
|
|
(13.3)
|
Profit before taxation
|
|
|
|
|
|
61.8
|
The Group analyses its net revenue
by the following categories:
|
2024
|
2023
|
|
£m
|
£m
|
Hygiene
|
289.1
|
334.8
|
Baby
|
106.9
|
123.1
|
Beauty
|
68.3
|
85.3
|
Electricals
|
56.6
|
105.4
|
Other
|
7.0
|
7.7
|
|
527.9
|
656.3
|
3. Adjusting items
Adjusting items expense/(income),
all of which are within continuing operations, comprise:
|
2024
£m
|
2023
£m
|
Simplification and
transformation1
|
10.1
|
2.9
|
Acquisition and disposal-related
items2
|
(1.4)
|
(0.7)
|
Impairment charge (net of impairment
reversal)1
|
24.4
|
10.1
|
Foreign exchange losses arising on
Nigerian Naira devaluation3
|
104.1
|
-
|
Foreign exchange losses arising on
Naira devaluation on joint venture4
|
3.4
|
-
|
Adjusting items before
taxation
|
140.6
|
12.3
|
Taxation
|
(30.6)
|
(4.7)
|
Adjusting items after
taxation
|
110.0
|
7.6
|
1 Included in administrative expense in the Consolidated Income
Statement.
2 Included in
finance income in the Consolidated Income Statement.
3 £79.0
million is included in cost of sales and £25.1 million is included
in administrative expense in the Consolidated Income Statement. The
amount in administrative expense includes charges of £0.2 million
and £1.4 million relating to the de-designation of permanent as
equity loans to a joint venture and fellow subsidiary undertakings
respectively.
4 Included in
share of results of joint venture in the Consolidated Income
Statement. This amount includes a credit of £1.2 million relating
to the de-designation of permanent as equity loans payable by a
joint venture undertaking to the Group.
Simplification and
transformation
For the year ended 31 May 2024,
these costs primarily relate to the following projects which
commenced in 2022: three-year finance transformation project, HR
simplification project and supply chain transformation project
which are due to be completed in 2025. In 2023, the profit on
disposal of properties in Nigeria was partially offset by costs
relating to the three-year finance transformation project, the HR
simplification project and supply chain transformation
project.
Acquisition and
disposal-related items
For the year ended 31 May 2024 and
31 May 2023, the income relates to the Childs Farm
acquisition.
Impairment charge (net of
impairment reversal)
The current year charge relates to
the impairment of the Sanctuary Spa brand (Note 7). In the prior
year the impairment charge, net of reversal, comprises a £16.5
million impairment of the Sanctuary Spa brand, a £4.2 million
reversal of a prior period impairment of the Rafferty's Garden
brand and a reversal of a £2.2 million previously recognised
impairment in the Group's investment in joint venture Wilmar PZ
International Pte. Limited, which was dissolved in May
2023.
Foreign exchange losses
arising on Nigerian Naira devaluation (including on joint
venture)
For the year ended 31 May 2024, this
primarily relates to realised and unrealised foreign exchange
losses resulting from the Nigerian Naira devaluation during the
financial year on USD denominated liabilities which existed at 31
May 2023. The closing NGN/GBP rate at reporting date was 1,893
(2023: 577), and the average NGN/GBP for the current year was 1,257
(2023: 536).
4.
Taxation
|
2024
|
2023
|
|
£m
|
£m
|
Current taxation
|
|
|
UK corporation tax
|
|
|
- current year
|
5.2
|
(2.2)
|
- adjustments in respect of prior
years
|
3.5
|
(0.3)
|
- double taxation relief
|
-
|
(0.5)
|
|
8.7
|
(3.0)
|
Overseas corporation tax
|
|
|
- current year
|
11.6
|
26.3
|
- adjustments in respect of prior
years
|
(0.8)
|
0.8
|
|
10.8
|
27.1
|
Total current taxation
charge
|
19.5
|
24.1
|
Deferred tax
|
|
|
Origination and reversal of temporary
timing differences
|
(38.0)
|
(6.2)
|
Adjustments in respect of prior
years
|
(6.4)
|
(2.3)
|
Effect of rate change
adjustments
|
0.8
|
(0.2)
|
Total deferred taxation
credit
|
(43.6)
|
(8.7)
|
Total taxation
(credit)/charge
|
(24.1)
|
15.4
|
Analysed as:
|
|
|
Taxation on (loss)/profit before
adjusting items
|
6.5
|
20.1
|
Taxation on adjusting
items
|
(30.6)
|
(4.7)
|
|
(24.1)
|
15.4
|
The effective tax rate in relation
to continuing operations for the year is 25.0% (2023: 24.9%).
Before adjusting items, the effective tax rate was 14.5% (2023:
27.1%), primarily due to the impact of the minimum tax regime in
Nigeria as a result of the recognised statutory operating losses,
and the tax deductibility of realised foreign exchange impacts
arising as a result of the cash repatriation from Nigeria to the
UK.
UK corporation tax is calculated at
25.0% (2023: 20.0%) of the estimated assessable profit for the
year. Taxation for other jurisdictions is calculated at the rates
prevailing in the respective jurisdictions. The Group has chosen to
use the UK corporation tax rate for the reconciliation of the
taxation charge for the year to the loss before taxation as this is
the seat for the central management and control of the
Group.
|
2024
|
2023
|
|
£m
|
£m
|
(Loss)/profit before tax
|
(95.9)
|
61.8
|
Tax at the UK corporation tax rate of
25% (2023: 20%)
|
(24.0)
|
12.4
|
Adjusted for:
|
|
|
Effect of non-deductible
expenses
|
6.4
|
2.2
|
Effect of non-taxable
income
|
(3.7)
|
(4.9)
|
Effect of rate changes on deferred
taxation (all territories)
|
0.8
|
(0.5)
|
Taxation effect of share of results
of joint ventures
|
(2.4)
|
(2.2)
|
Other taxes suffered outside of the
UK
|
2.1
|
3.2
|
Net adjustment to amount carried in
respect of uncertain tax positions
|
2.4
|
(0.8)
|
Movements in deferred taxation assets
not recognised
|
1.7
|
(0.6)
|
Adjustments in respect of prior
years
|
(3.7)
|
(1.5)
|
Differences in overseas
rates
|
(3.7)
|
8.1
|
Tax (credit)/charge for the
year
|
(24.1)
|
15.4
|
5.
Dividends
|
2024
|
2023
|
|
£m
|
£m
|
Amounts recognised as distributions to ordinary shareholders
in the year comprise:
|
|
|
Final dividend for the year ended 31
May 2023 of 3.73p (2022: 3.73p) per ordinary share
|
15.6
|
15.6
|
Interim dividend for the year ended
31 May 2024 of 1.50p (2023: 2.67p) per ordinary share
|
6.3
|
11.2
|
|
21.9
|
26.8
|
After the balance sheet date, the
Board announced its intention to declare an interim dividend of
2.10p per share, down 44% compared to last year's final dividend of
3.73p. This represents a full year dividend of 3.60p which is also
down 44%, reflecting the impact of the Naira devaluation on
earnings per share while maintaining an earnings cover of
approximately two times. This results in a total dividend of
£8.8 million (2023: £15.6 million). The dividend will be paid on 4
December 2024 to the shareholders on the register on 1 November
2024. The proposed dividend has not been included as a liability in
the consolidated financial statements as at 31 May 2024.
6.
(Loss)/earnings per share
Earnings per share (EPS) represents
the amount of earnings attributable to each ordinary share in
issue. Basic EPS is calculated by dividing the earnings (profit
after tax attributable to owners of the Parent) by the weighted
average number of ordinary shares in issue during the year,
excluding own shares owned by employee trusts.
For diluted EPS, the weighted
average number of ordinary shares in issue is adjusted to assume
conversion of all dilutive potential ordinary shares. The Group's
dilutive potential ordinary shares relate to awards granted under
the Group's share incentive schemes. For the year ended 31 May
2024, the basic and diluted EPS are equal as a result of the Group
incurring a loss for the year.
The average number of shares is
reconciled to the basic weighted average and diluted weighted
average number of shares as set out below:
|
2024
number
|
2023
number
|
|
000
|
000
|
Average number of ordinary shares in
issue during the year
|
428,725
|
428,725
|
Less: weighted average number of
shares held by employee trusts
|
(9,693)
|
(10,180)
|
Basic weighted average shares in issue during the
year
|
419,032
|
418,545
|
Dilutive effect of share incentive
schemes
|
1,064
|
1,530
|
Diluted weighted average shares in issue during the
year
|
420,096
|
420,075
|
An adjusted EPS measure is provided
which calculates EPS excluding adjusting items from profits
attributable to owners of the Parent. The Directors believe that
the separate disclosure of adjusting items is relevant to an
understanding of the Group's financial performance, and excluding
such items provides a more meaningful basis upon which to analyse
underlying business performance and make year-on-year
comparisons.
7.
Goodwill and other intangible assets
|
Goodwill
£m
|
Software
£m
|
Brands
£m
|
Total
£m
|
Cost
|
|
|
|
|
At 1 June 2022
|
68.2
|
65.6
|
270.3
|
404.1
|
Additions
|
-
|
2.0
|
-
|
2.0
|
Disposals
|
-
|
(0.5)
|
-
|
(0.5)
|
Transfers to property, plant and
equipment
|
-
|
(0.4)
|
-
|
(0.4)
|
Exchange differences
|
(1.6)
|
(0.1)
|
(3.1)
|
(4.8)
|
At
31 May 2023
|
66.6
|
66.6
|
267.2
|
400.4
|
Additions
|
-
|
0.4
|
-
|
0.4
|
Exchange differences
|
-
|
(1.5)
|
-
|
(1.5)
|
At
31 May 2024
|
66.6
|
65.5
|
267.2
|
399.3
|
|
|
|
|
|
Accumulated amortisation and
impairment
|
|
|
|
|
At 1 June 2022
|
11.1
|
34.6
|
24.5
|
70.2
|
Amortisation charge
|
-
|
7.0
|
-
|
7.0
|
Impairment charge
|
-
|
-
|
16.5
|
16.5
|
Impairment reversal
|
-
|
-
|
(4.2)
|
(4.2)
|
Exchange differences
|
(0.9)
|
-
|
(0.4)
|
(1.3)
|
At
31 May 2023
|
10.2
|
41.1
|
36.4
|
87.7
|
Amortisation charge
|
-
|
7.1
|
-
|
7.1
|
Impairment charge
|
-
|
-
|
24.4
|
24.4
|
Exchange differences
|
1.7
|
(1.0)
|
0.1
|
0.8
|
At
31 May 2024
|
11.9
|
47.2
|
60.9
|
120.0
|
|
|
|
|
|
Net book value
|
|
|
|
|
At
31 May 2024
|
54.7
|
18.3
|
206.3
|
279.3
|
At 31 May 2023
|
56.4
|
25.5
|
230.8
|
312.7
|
Amortisation and impairment are
charged to administrative expense in the Consolidated Income
Statement. Cumulative impairment of goodwill as at 31 May 2024 was
£10.2 million (2023: £10.2 million) and cumulative impairment of
brands as at 31 May 2024 was £60.9 million (2023: £36.4
million).
Software includes the Group's
enterprise resource planning system (SAP), which is internally
developed, and the carrying value of this asset as at 31 May 2024
is £13.7 million (2023: £20.6 million), with three years of
amortisation remaining.
Other than software, intangible
assets comprise goodwill and brands. Goodwill and brands have all
arisen from previous business combinations and all have indefinite
useful lives and, in accordance with IAS 36 Impairment of Assets,
are subject to annual impairment testing (which the Group carries
out at the year-end date), or more frequently if there are
indicators of impairment.
The method used for impairment
testing is to allocate assets to appropriate cash-generating units
(CGUs) based on the smallest identifiable group of assets that
generate independent cash inflows, and to estimate the recoverable
amounts of the CGUs as the higher of the assets' fair values less
costs of disposal and the value-in-use. Impairment testing is a
two-step approach commencing with the testing of brands with an
indefinite useful life. Each brand is considered its own CGU for
this purpose. The second step is to test goodwill for impairment.
For the purposes of this test, goodwill acquired is
allocated to the CGUs or groups of CGU expected to benefit from the
synergies of the business combination. For this purpose goodwill
related to each of the beauty brands is aggregated together into
the Beauty CGU as this is manner in which the core assets are used
to generate cash flows and is the lowest level at which goodwill is
monitored by management.
Value-in-use is determined using
cash flow projections from approved budgets and plans which are
then extrapolated based on estimated long-term growth rates
applicable to the markets and geographies in which the CGUs
operate. The cash flow projections are discounted based on a
pre-tax weighted average cost of capital for comparable companies
operating in similar markets and geographies as the Group adjusted
for risks specific to the particular CGU.
Goodwill of £54.7 million (2023:
£56.4 million) comprises £40.4 million (2023: £40.4 million) in
relation to the acquisitions of the Group's Beauty brands (Charles
Worthington, Fudge, Sanctuary Spa and St.Tropez), £13.5 million
(2023: £13.5 million) in relation to the acquisition of Childs Farm
and £0.8 million (2023: £2.5 million) in relation to other
acquisitions. The movement in other goodwill in the current year
relates to exchange differences. Goodwill for the Beauty brands is
assessed at the Group of CGUs comprising these brands (see table
below) as this represents the lowest level at which goodwill is
monitored by management.
The carrying value of goodwill and
each brand is set out in the table below. For the impairment
testing of brands, each brand is allocated to a single CGU. For the
impairment testing of goodwill, Childs Farm goodwill is allocated
to the same CGU as the brand and, as noted above, Beauty goodwill
is allocated to the Group of CGUs comprising the Beauty
brands:
|
Goodwill
2024
£m
|
Brands
2024
£m
|
Goodwill
2023
£m
|
Brands
2023
£m
|
Charles Worthington
|
|
9.6
|
|
9.6
|
Fudge
|
|
24.6
|
|
24.6
|
Sanctuary Spa
|
|
34.5
|
|
58.9
|
St. Tropez
|
|
58.4
|
|
58.4
|
Beauty
|
40.4
|
127.1
|
40.4
|
151.5
|
Original Source
|
-
|
9.8
|
-
|
9.8
|
Rafferty's Garden
|
-
|
33.9
|
-
|
33.9
|
Childs Farm
|
13.5
|
35.5
|
13.5
|
35.5
|
Other
|
0.8
|
-
|
2.5
|
-
|
|
54.7
|
206.3
|
56.4
|
230.8
|
In performing the impairment
testing, the Group used the five-year plan ending 31 May 2029.
Assumptions in the budgets and plans used for the value in use cash
flow projections include future revenue volume and price growth
rates, associated future levels of marketing support, the cost base
of manufacture and supply and directly associated overheads. These
assumptions are based on historical trends and future market
expectations specific to each CGU and the markets and geographies
in which each CGU operates.
The key assumptions applied in
determining value-in-use are the long-term growth rate and the
discount rate, both of which are determined with reference to the
markets and geographies in which the CGU (or group of CGUs)
operates, and revenue growth and gross margin.
The compound annual growth rates,
long-term growth rates and discount rates applied in the value in
use calculations used in impairment tests were:
|
CAGR1
2024
|
CAGR1
2023
|
Long-term
growth rate
2024
|
Long-term
growth
rate
2023
|
Pre-tax
discount
rate
2024
|
Pre-tax
discount
rate
2023
|
Charles Worthington
|
6.1%
|
3.4%
|
2.0%
|
2.0%
|
11.5%
|
10.1%
|
Fudge
|
2.3%
|
6.8%
|
2.0%
|
2.0%
|
11.7%
|
10.7%
|
Sanctuary Spa
|
2.8%
|
3.0%
|
2.0%
|
2.0%
|
11.5%
|
10.2%
|
St. Tropez
|
3.3%
|
3.5%
|
2.0%
|
2.0%
|
12.0%
|
10.4%
|
Beauty group of CGUs (goodwill
assessment)
|
3.2%
|
3.9%
|
2.0%
|
2.0%
|
11.6%
|
10.4%
|
Original Source
|
9.9%
|
3.2%
|
2.0%
|
2.0%
|
11.6%
|
10.5%
|
Rafferty's Garden
|
4.5%
|
4.1%
|
2.5%
|
2.5%
|
11.8%
|
10.6%
|
Childs Farm (brand and goodwill
assessment)
|
19.6%
|
27.5%
|
2.0%
|
2.0%
|
11.7%
|
12.2%
|
1 CAGR refers to the compound
annual revenue growth rate over the five-year plan
period.
The results of the impairment tests
as at 31 May 2024 were as follows:
Sanctuary Spa
In the year ended 31 May 2024,
there was an impairment charge of £24.4 million (2023: £16.5
million) relating to the Sanctuary Spa brand, charged to
administrative expense in the Consolidated Income Statement and
included in the Europe & the Americas segment. The recoverable
amount reflected the cost-of-living pressures and their impact on
price sensitive beauty products. The recoverable amount of the CGU
was determined to be £40.4 million based on a value-in-use
calculation, which when compared to a carrying value of £64.8
million (of which the brand represented £58.9 million) resulted in
an impairment charge of £24.4 million. The long-term growth rate
and discount rate used in the value in use calculations were 2.0%
and 11.5% respectively.
Management has determined gross
margin and compound annual revenue growth rate to be the key
assumptions in the forecasts for Sanctuary Spa. Sensitivity
analysis has been carried out in the year ended 31 May 2024 and a
reasonably possible change of 250bps decline in gross margin within
the five-year forecast period would increase the impairment charge
by £7.6 million, a 200bps decline in the annual revenue growth rate
over the five-year plan period, which results in a five-year
compound annual revenue growth rate of 0.8%, would increase the
impairment charge by £8.4 million and a 100bps increase in the
discount rate would increase the impairment charge by £4.9 million.
A reduction of 0.1% in compound annual revenue growth rate over the
five-year plan would result in zero headroom. The same impact would
be caused by a decline of 0.1% in gross margin or an increase of
0.1% in discount rate.
7.
Goodwill and other intangible assets (continued)
Charles Worthington
For the Charles Worthington brand,
the recoverable amount of the applicable CGU which was based on a
value in use calculation was determined to be £11.8 million which
is in excess of the carrying value of £10.9 million (of which the
brand represented £9.6 million).
Management have determined gross
margin and compound annual revenue growth rate to be the key
assumptions in the forecasts for Charles Worthington. Sensitivity
analysis has been carried out in the year ended 31 May 2024 and a
reasonably possible change of 250bps decline in gross margin within
the five-year forecast period would result in an impairment charge
of £1.1million, a 200bps decline in annual revenue growth rate
within the five-year forecast period, which results in a five-year
compound annual revenue growth rate of 4.1%, would result in an
impairment charge of £1.5 million and a 100bps increase in the
discount rate would result in an impairment charge of £0.7 million.
A reduction of 0.7% in compound annual revenue growth rate over the
five-year plan would result in zero headroom. The same impact would
be caused by a decline of 1.2% in gross margin or an increase of
0.6% in discount rate.
Rafferty's Garden
For the Rafferty's Garden brand,
the recoverable amount of the applicable CGU based on a
value-in-use calculation was determined to be £38.4 million,
exceeding the carrying value of £34.9 million (of which the brand
represented £33.9 million). The recoverable amount reflected
expected growth from new product development and recovery in gross
margin arising from cost savings in raw materials. Historical
impairment charges were fully reversed in the prior
year.
Management has determined gross
margin and compound annual revenue growth rate to be the key
assumptions in the forecasts for Rafferty's Garden. Sensitivity
analysis has been carried out in the year ended 31 May 2024 and a a
reasonably possible change of 250bps decline in gross margin within
the five-year forecast period would result in an impairment charge
of £7.2million, a 200bps decline in annual revenue growth rate
within the five-year forecast period, which results in a five-year
compound annual revenue growth rate of 2.5%, would result in an
impairment charge of £5.5 million and a 100bps increase in the
discount rate would result in an impairment charge of £2.5 million.
A reduction of 0.7% in compound annual revenue growth rate over the
five-year plan would result in zero headroom. The same impact would
be caused by a decline of 0.8% in gross margin or an increase of
0.5% in discount rate.
Other CGUs
For the remaining CGUs, the
recoverable amounts of the respective applicable CGUs, which were
determined based on value in use calculations, exceeded the
carrying values. Sensitivity analysis on the value in use
calculations did not identify potential impairment in relation to a
reasonably possible downside in the assumptions used for the
projections.
8.
Cash and cash equivalents and net debt
Cash and cash equivalents include
cash at bank and in hand, short-term deposits and other highly
liquid investments with original maturities of three months or less
which are readily convertible into known amounts of cash with
insignificant risk of changes in value.
Borrowings comprise bank overdrafts,
short-term uncommitted loans and amounts drawn under the Group's
committed credit facility. Bank overdrafts are repayable on demand
and form a part of the Group's cash management activities. Further
details on the Group's committed credit facility are provided in
Note 19. The Group defines net debt as cash and cash equivalents
net of borrowings, and net debt including lease liabilities as cash
and cash equivalents net of borrowings and lease
liabilities.
Group net debt comprises the
following:
|
1 June 2023
£m
|
Net cash
flow
£m
|
Foreign
exchange
movements
£m
|
Other1
£m
|
31 May 2024
£m
|
Cash at bank and in hand
|
127.4
|
(22.7)
|
(55.3)
|
-
|
49.4
|
Short term deposits
|
129.0
|
(61.7)
|
(65.4)
|
-
|
1.9
|
Cash and cash equivalents
|
256.4
|
(84.4)
|
(120.7)
|
-
|
51.3
|
Current asset
investments
|
0.5
|
(0.5)
|
-
|
-
|
-
|
Current borrowings
|
-
|
(6.4)
|
0.1
|
-
|
(6.3)
|
Non-current borrowings
|
(251.2)
|
91.0
|
-
|
(0.1)
|
(160.3)
|
Net cash/(debt)
|
5.7
|
(0.3)
|
(120.6)
|
(0.1)
|
(115.3)
|
Lease liabilities
|
(13.0)
|
2.9
|
0.2
|
(2.2)
|
(12.1)
|
Net debt including lease liabilities
|
(7.3)
|
2.6
|
(120.4)
|
(2.3)
|
(127.4)
|
1 Other includes lease additions and an increase in the lease
liability arising from the unwinding of interest
element.
At 31 May 2024, the Group had
restricted cash of £0.7 million (2023: £0.7 million).
At 31 May 2024, £20.0 million
(2023: £204.1 million) of the cash and cash equivalents was held by
the Group's Nigerian subsidiaries. At 31 May 2024, the Sterling
equivalent of Nigerian Naira cash balances are materially reduced,
both as a result of the devaluation of the Nigerian Naira occurring
during FY24 and the successful cash repatriation from Nigeria to
the UK.
Borrowings are amounts drawn under
both committed and uncommitted borrowing facilities. The Group has
a £325.0 million committed credit facility which is available for
general corporate purposes. The credit facility incorporates both a
term loan, of up to £125.0 million, with the balance as a revolving
credit facility (RCF) structure. Entered
into in November 2022, the term loan is a two-year facility and the
RCF a four-year facility, with both facilities retaining two,
one-year extension options, the first of which was executed in
October 2023. Drawings under the term loan are permitted in GBP,
and under the RCF in GBP, Euros or USD, at interest rates at a
margin of 1.30-2.10% above SONIA, EURIBOR or SOFR, dependent on
leverage and the attainment of specified sustainability performance
targets.
Non-current borrowings as at 31 May
2024 are presented net of £0.7 million (2023: £0.8 million) of
unamortised financing fees. As at 31 May 2024, this facility was
£161.0 million drawn (2023: £252.0 million).
Borrowings as at 31 May 2024, which
are presented net of £0.7 million (2023: £0.8 million) of
unamortised financing fees, comprise £125.0 million (2023: £125.0
million) of term loans which are denominated in GBP at an interest
rate of 6.79% (2023: 5.73%), and £36.0 million (2023: £127.0
million) of borrowings under the RCF which are denominated in GBP
at interest rates at between 6.78%-6.79% (2023:
5.66%-5.78%).
In addition, the Group retains other
unsecured and uncommitted facilities that are primarily used for
trade-related activities in Nigeria where ordinary trading
activities are required to be supported by letters of credit (or
similar). As at 31 May 2024, these amounted to £161.6 million
(2023: £199.8 million) of which £40.3 million, or 25% were utilised
(2023: £93.3 million or 47%). The utilisation amount has decreased
during the reporting period as a result of the improvement in
access to foreign currency which in turn has facilitated the
settlement of USD liabilities. As at the reporting date, there were
no bank overdrafts (2023: £nil).
9.
Reconciliation of (loss)/profit before taxation to cash generated
from operations
|
2024
|
2023
|
|
£m
|
£m
|
(Loss)/profit before taxation
|
(95.9)
|
61.8
|
Net finance expense/(income) and net
monetary loss arising from hyperinflationary economies
|
12.2
|
(2.1)
|
Operating (loss)/profit
|
(83.7)
|
59.7
|
Depreciation
|
10.2
|
12.1
|
Amortisation
|
7.1
|
7.0
|
Impairment of tangible and intangible
assets
|
24.4
|
16.5
|
Impairment reversal of intangible
assets
|
-
|
(4.2)
|
Impairment reversal of net
investments in joint venture
|
-
|
(2.2)
|
Impairment of current asset
investment
|
0.5
|
-
|
Profit on sale of assets
|
(1.8)
|
(11.1)
|
Difference between pension charge and
cash contributions
|
1.7
|
0.5
|
Share-based payments
|
1.9
|
1.7
|
Share of results of joint
venture
|
(7.3)
|
(7.5)
|
Operating cash flows before movements
in working capital
|
(47.0)
|
72.5
|
Movements in working
capital:
|
|
|
Inventories
|
2.3
|
(8.4)
|
Trade and other
receivables
|
15.3
|
(13.4)
|
Trade and other payables
|
77.5
|
30.3
|
Provisions
|
(0.4)
|
(4.4)
|
Cash generated from
operations
|
47.7
|
76.6
|
10. Post balance sheet
events
There are no material post balance
sheet events.
11. Directors' confirmations
Each of the Directors confirm that,
to the best of their knowledge:
· The
Group financial statements within the full Annual Report and
Accounts, which have been prepared in accordance with UK-adopted
international accounting standards, give a true and fair view of
the assets, liabilities, financial position and profit of the Group
and
· The
Strategic Report within the full Annual Report and Accounts
includes a fair review of the development and performance of the
business and the position of the Group, together with a description
of the principal risks and uncertainties that it faces.
Approved by the Board of Directors
on 18 September 2024